Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Steroids|March 9, 2010
Synthesis of regioisomeric 17beta-N-phenylpyrazolyl steroid derivatives and their inhibitory effect on 17alpha-hydroxylase/C(17,20)-lyaseZoltán Iványi, János Wölfling, Tamás Görbe, et al.Digestion|July 19, 2008
Asthma and gastroesophageal reflux: clinical evaluation of esophago-bronchial reflex and proximal refluxAndrás Rosztóczy, László Makk, Ferenc Izbéki, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|December 22, 2011
Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patientsTamás Molnár, Klaudia Farkas, Tibor Nyári, et al.World Journal of Gastroenterology|June 13, 2012
Association between autoimmune pancreatitis and systemic autoimmune diseasesViktória Terzin, Imre Földesi, László Kovács, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|September 27, 2012
Frequency and predictors of loss of response to infliximab or adalimumab in Crohn's disease after one-year treatment period - a single center experienceTamás Molnár, Klaudia Farkas, Tibor Nyári, et al.Scandinavian Journal of Gastroenterology|October 22, 2013
Long-term increase in serum cholesterol levels in ulcerative colitis patients treated with cyclosporine: an underdiagnosed side effect frequently associated with other drug-related complicationsAnita Bálint, Klaudia Farkas, Mónika Szűcs, et al.Digestive Diseases and Sciences|December 18, 2007
Increased prevalence of gallstone disease and impaired gallbladder motility in patients with Barrett's esophagusFerenc Izbéki, András I Rosztóczy, John Sebit Yobuta, et al.Orvosi Hetilap|May 26, 2011
[Frequency and possible reasons for the loss of response to biological therapy in Crohn's disease after a one-year treatment period]Tamás Molnár, Klaudia Farkas, Tibor Nyári, et al.Orvosi Hetilap|June 13, 2008
[Amyloidosis induced colonic stricture. The first symptom of myeloma multiplex. A case report]Anita Annaházi, István Németh, Szabolcs Modok, et al.European Journal of Pharmacology|June 3, 2009
Simultaneous proteosome inhibition and heat shock protein induction by bortezomib is beneficial in experimental pancreatitisAnnamária Szabolcs, György Biczó, Zoltán Rakonczay, et al.Pageof 8